Johanna Haggstrom - Feb 8, 2023 Form 4 Insider Report for LanzaTech Global, Inc. (LNZA)

Role
VP, Chemicals & HC Fuels Tech
Signature
/s/ Joseph Blasko, as Attorney-in-Fact
Stock symbol
LNZA
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 08:43 PM
Next filing
May 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNZA Stock Options Award +10K 10K Feb 8, 2023 Common Stock 43.7K $1.09 Direct F1, F3
transaction LNZA Stock Options Award +5K 5K Feb 8, 2023 Common Stock 21.9K $3.15 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the options are vested and exercisable, 25% vests on each of September 18, 2023 and September 18, 2024.
F2 25% of the options vested on on December 24, 2022, the remaining options vest monthly thereafter over 36 months.
F3 On February 8, 2023, AMCI Acquisition Corp. II ("AMCI") consummated a business combination (the "Business Combination") by and among AMCI, AMCI Merger Sub, Inc., a Delaware corporation ("AMCI Merger Sub") and LanzaTech NZ, Inc., a Delaware corporation ("Legacy LanzaTech"), AMCI changed its name to "LanzaTech Global, Inc." and AMCI Merger Sub merged with and into Legacy LanzaTech. As part of the Business Combination, each Legacy LanzaTech stock option was exchanged for a stock option to acquire 4.374677 shares of common stock of LanzaTech Global, Inc.